Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
POSTED
04-24-20
Committed to Reducing Greenhouse Gas Emissions for a Healthier World
Gilead views environmental stewardship as critical to help the company achieve its mission and last year announced a goal to reduce gr...
POSTED
04-14-20
Ramping Up Manufacturing to Help Address COVID-19
As the number of confirmed COVID-19 cases increased in Asia and began to spread to other regions around the world, a team of employees at Gilead’s manufacturing site in La Verne, California met in the early morning of Monday, Feb. 3.
The topic of the meeting: How quickly could the site beg...
POSTED
04-02-20
An Open Letter from our Chairman and CEO
Daniel O'Day
When the news of the coronavirus first emerged, Gilead immediately began to investigate the potential of remdesivir, a medicine we had been studying for many years as part of our extensive research in antivirals. Remdesivir had never been approved for use but based on...
POSTED
03-25-20
Gilead Sciences Statement on Ensuring Continued Supply of HIV Medicine Amid Coronavirus Outbreak
For those with potentially immunosuppressing conditions, such as HIV, the uncertainty caused by the novel coronavirus pandemic can be particularly challenging. Gilead remains focused on ensuring that people living with or at risk for HIV have access to the medications and ...
POSTED
03-19-20
Profiles in Creating Possible: Bismay Mishra Advocates for Transgender Equity
Educating people about gender identities and sexual orientation can be challenging to navigate in any setting – let alone at a company with employees from diverse backgrounds al...
POSTED
03-12-20
Profiles in Creating Possible: Julie Di Paolo is on a Mission to Understand Rheumatoid Arthritis and Other Inflammatory Diseases
When Julie Di Paolo’s father was diagnosed with Crohn’s disease, an inflammatory condition with limited treatment options, it sparked curiosity and drive that have carried forwa...
POSTED
03-06-20
Profiles in Creating Possible: Staci Bush Helps Gilead Go Beyond Medicine to Address Barriers to HIV Care Through Partnerships
Staci Bush can still remember the first time that she, while working as a physician’s assistant at an LGBTQ+ teen health center in Chicago, became aware of the term “single tablet ...
POSTED
08-08-16
Gilead Publishes 2015 Corporate Social Responsibility Report
Gilead Sciences, Inc. has issued its first Corporate Social Responsibility Report, which provides an overview of the work the company is doing around the world to improve the lives of people with life-threatening diseases and to make a positive impact on public health and local communities.
...